Dear all,
The Alpha package of the July 2018 Drugs and Substances release is now available for your review.
USE WITHIN CLINICAL SYSTEMS CANNOT BE SUPPORTED AT THIS TIME.
The Alpha release represents a proof of concept and is distributed for evaluation purposes only. It is not for use in production clinical systems or in clinical settings.
The full RF2 release package is available here, from the “January 2018 v0.1” version in the “SNOMED CT Drugs and Substances Alpha package - SNOMED International” project, which can be found in the "Offline & Alpha/Beta Releases” section on the “IHTSDO Releases” page in MLDS, accessed here:
https://mlds.ihtsdotools.org/#/ihtsdoReleases
A separate instance of the SNOMED CT Browser has been created to enable effective review of the content - this can be accessed here:
The Release Notes are attached, and can also be accessed here online:
Please provide feedback before 15th March 2018, via the relevant feedback forms, which can be found here:
- https://confluence.ihtsdotools.org/display/IAP/Alpha+Release+of+Drugs+28-FEB-2018
- https://confluence.ihtsdotools.org/display/IAP/Alpha+Release+of+Substances+28-FEB-2018
If you have any questions about the Drugs and Substances content, please contact SNOMED International at support@snomed.org with the subject line as “Alpha release of the July 2018 Drugs and Substances release”.
Kind regards,
Andrew Atkinson | Release Manager
xdoc_SnomedCT-DRUGSandSUBSTANCES-Alpha-ReleaseNotes_Current-en-US_INT_20180228.pdf